Capital Fund Management (CFM)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
+21,871
| New | +$306K | ﹤0.01% | 823 |
|
|
2022
Q2 | – | Sell |
-13,443
| Closed | -$432K | – | 708 |
|
|
2022
Q1 | $432K | Sell |
13,443
-360
| -3% | -$11.6K | ﹤0.01% | 553 |
|
|
2021
Q4 | $616K | Sell |
13,803
-3,202
| -19% | -$143K | ﹤0.01% | 493 |
|
|
2021
Q3 | $858K | Buy |
17,005
+5,204
| +44% | +$263K | 0.01% | 441 |
|
|
2021
Q2 | $926K | Sell |
11,801
-40,518
| -77% | -$3.18M | 0.01% | 431 |
|
|
2021
Q1 | $2.99M | Buy |
+52,319
| New | +$2.99M | 0.03% | 235 |
|